Posttraumatic stress disorder in adulthood after the experience of childhood maltreatment: Does attachment to foster or biological parents make a difference?
Psychological Trauma: Theory, Research, Practice, and Policy · 2025
DOI: 10.1037/tra0001898 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychological Trauma: Theory, Research, Practice, and Policy, 2025. Verfasst von Raphaële Miljkovitch und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire Paragraphe, Universite Paris 8. Hauptthemen laut MEDLINE: Stress Disorders, Post-Traumatic, Object Attachment, Adult Survivors of Child Abuse, Parent-Child Relations.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Laboratoire Paragraphe, Universite Paris 8.
- Laboratoire Clinique Psychanalyse Developpement, Universite Paris Nanterre.
ORCID-Profile: Raphaële Miljkovitch
Zitieren
APA
Miljkovitch, R., Danner Touati, C., Sirparanta, A. E., Toléon, C., & Deborde, A. S. (2025). Posttraumatic stress disorder in adulthood after the experience of childhood maltreatment: Does attachment to foster or biological parents make a difference?. Psychological Trauma: Theory, Research, Practice, and Policy. https://doi.org/10.1037/tra0001898
Vancouver
Miljkovitch R, Danner Touati C, Sirparanta AE, Toléon C, Deborde AS. Posttraumatic stress disorder in adulthood after the experience of childhood maltreatment: Does attachment to foster or biological parents make a difference?. Psychological Trauma: Theory, Research, Practice, and Policy. 2025. doi:10.1037/tra0001898
BibTeX
@article{Miljkovitch2025,
author = {Miljkovitch, Raphaële and Danner Touati, Camille and Sirparanta, Aino Elina and Toléon, Camille and Deborde, Anne-Sophie},
title = {Posttraumatic stress disorder in adulthood after the experience of childhood maltreatment: Does attachment to foster or biological parents make a difference?},
journal = {Psychological Trauma: Theory, Research, Practice, and Policy},
year = {2025},
doi = {10.1037/tra0001898}
}
EUVIMED